Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1321-1330 of 10621

Edit search filters
  1. A Study to Evaluate the Safety of Lixivaptan in Subjects Previously Treated with Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  2. A Study to Assess CT Scalar Localization of the Electrode Array Following Cochlear Implantation

    Rochester, MN

  3. OTL38 for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

  4. VE303 for Prevention of Recurrent Clostridioides Difficile Infection (RESTORATiVE303)

    Scottsdale/Phoenix, AZ

  5. Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Jacksonville, FL

  6. Intraoperative Endoscopy Using Flexible Cholangiopancreatoscope

    Rochester, MN

  7. An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

    Rochester, MN

  8. Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis

    Jacksonville, FL

  9. Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

    Jacksonville, FL

  10. Phase 1a/​1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer